MedTrace Logo

Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

NCT05350891 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2022-05-10

No results posted yet for this study

Summary

A Prospective, Single-arm, Multicenter Clinical Study of Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent Nasopharyngeal Carcinoma

Conditions

  • Recurrent Nasopharyngeal Carcinoma

Interventions

PROCEDURE

endoscopic surgery

endoscopic surgery combined with adjuvant immunotherapy with/without chemotherapy

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences

    collaborator OTHER

  • Eye & ENT Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Hongmeng Yu, MD,PHD · Eye&ENT Hospital,Fudan University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-08
Primary Completion
2026-05-08
Completion
2026-05-08

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05350891 on ClinicalTrials.gov